Download Free Pandemic Medicine Book in PDF and EPUB Free Download. You can read online Pandemic Medicine and write the review.

This guidance is an update of WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics, published March 2005 (WHO/CDS/CSR/GIP/2005.5).
A practical action plan for reinventing healthcare in a post-pandemic world—from a physician-entrepreneur who works with Fortune 500 companies. If the healthcare system were an emperor, Covid-19 tragically revealed that it had no clothes. Healthcare had to adapt, and quickly―sparking a dramatic acceleration of virtual care, drive-through testing, and home-based services. In the process, old rules were rewritten and, perhaps surprisingly, largely in a good way for patients. To succeed in the post-pandemic world, all of us―patients, caregivers, providers, employers, investors, technologists, and policymakers―need to understand the new healthcare landscape and change our strategies and behaviors accordingly. In Care After Covid, practicing physician and business leader Dr. Shantanu Nundy—Chief Medical Officer of Accolade, which provides technology-enabled health services to Fortune 500 companies as well as small businesses―lays out a comprehensive plan to transform healthcare along three dimensions: Distributed: healthcare will happen where health happens. It will shift from where doctors are to where patients are—at home, in the community, and increasingly on their phones. Digitally enabled: healthcare and the relationships that are central to care will be strengthened by data and technology. It will shift from being siloed to connected, from being episodic to continuous, from one-size-fits-all to more personalized. Decentralized: healthcare decisions and resources will be in the hands of those closest to care. The power to determine who gets care and how they get it will shift away from governments and insurance companies to communities, employers, doctors, and patients. Filled with firsthand insights and stories from the frontlines of healthcare—as well as innovative solutions that were proven effective before and during the pandemic—Care After Covid shows all stakeholders in the healthcare ecosystem exactly what needs to change and, more importantly, how to do it. The time to act is now. We can’t afford not to.
The spring of 2020 marked a change in how almost everyone conducted their personal and professional lives, both within science, technology, engineering, mathematics, and medicine (STEMM) and beyond. The COVID-19 pandemic disrupted global scientific conferences and individual laboratories and required people to find space in their homes from which to work. It blurred the boundaries between work and non-work, infusing ambiguity into everyday activities. While adaptations that allowed people to connect became more common, the evidence available at the end of 2020 suggests that the disruptions caused by the COVID-19 pandemic endangered the engagement, experience, and retention of women in academic STEMM, and may roll back some of the achievement gains made by women in the academy to date. Impact of COVID-19 on the Careers of Women in Academic STEMM identifies, names, and documents how the COVID-19 pandemic disrupted the careers of women in academic STEMM during the initial 9-month period since March 2020 and considers how these disruptions - both positive and negative - might shape future progress for women. This publication builds on the 2020 report Promising Practices for Addressing the Underrepresentation of Women in Science, Engineering, and Medicine to develop a comprehensive understanding of the nuanced ways these disruptions have manifested. Impact of COVID-19 on the Careers of Women in Academic STEMM will inform the academic community as it emerges from the pandemic to mitigate any long-term negative consequences for the continued advancement of women in the academic STEMM workforce and build on the adaptations and opportunities that have emerged.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of non-communicable diseases (NCD). The report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
Spreading to every corner of the Earth, the COVID-19 virus has had an unparalleled impact on all aspects of our lives. This book explores in detail how the COVID-19 pandemic has affected clinical practice, education, and research in medical physics, and how colleagues on the frontline dealt with this unpredictable and unprecedented pandemic. It tackles key questions such as: How did medical physicists first respond to the situation? What innovative strategies were taken and how effective were they? How are medical physicists preparing for the future? There will be a focus on the different experiences of regional medical physicists and the responses and outlooks in clinical practice, education, and research in the affected continents, Asia-Pacific, the Middle East, Europe, Africa and North and Latin America. With over 91 contributors from 39 countries, this unique resource contains key perspectives from teams from each territory to ensure a global range of accounts. The collective opinion and wisdom from the major medical physics journal editors-in-chief are also explored, alongside how the pandemic has affected the quantity and quality of publications. Voices of early-career researchers and students of medical physics will be included, with narratives of their experiences coping with life during the pandemic. Lastly, communicating leadership in times of adversity is highlighted. This book will be a historic account of the impact of the COVID-19 virus on the field of medical physics. It will be an ideal reference for medical physicists, medical physics trainees and students, hospital administrators, regulators, and healthcare professionals allied with medical physics. Key features: The first book to cover the impact of COVID-19 on the field of medical physics Edited by two experts in the field, with chapter contributions from subject area specialists around the world Broad, global coverage, ranging from the impact on teaching, research, and publishing, with unique perspectives from journal editors and students and trainees
This report offers insights into the risks and vulnerabilities of the supply chains of medicines and medical devices. Policy options to anticipate and mitigate risks of shortages of medicines and medical devices, both routinely and in the context of severe crises, are analysed. Most importantly, the report shows that strengthening the long-term resilience of medical supply chains requires collaborative approaches that balance measures best undertaken by the private sector with those more appropriately managed by governments or supranationally.